Difference between revisions of "Rhabdoviridae"
Line 126: | Line 126: | ||
##*The current vaccine is grown in human diploid cells (HDCV) and is BPL-inactivated, and therefore costly | ##*The current vaccine is grown in human diploid cells (HDCV) and is BPL-inactivated, and therefore costly | ||
##*Developing countries utilize older vaccines passaged from a 1939 case ("Flury" vaccines) | ##*Developing countries utilize older vaccines passaged from a 1939 case ("Flury" vaccines) | ||
− | ##If | + | ##If bitten and unvaccinated: |
##*Clean and disinfect wound | ##*Clean and disinfect wound | ||
##*Human '''anti-rabies immunoglobulin''' administered around bite | ##*Human '''anti-rabies immunoglobulin''' administered around bite |
Revision as of 22:03, 13 October 2008
This article is still under construction. |
|
Introduction
Rabies is a neurological killer that has evolved a fool-proof technique of transmission, and it cleverly evades the species barrier to present a potent threat to mammalian life. While the simplicity of the virus insures its transmission, it also contributes to its weakness: its monoclonal antigenicity means that a single vaccination covers all strains of the disease. Though rabies is considered endemic in parts of the developed and undeveloped world, vaccination schemes have rendered the disease controllable to a satisfactory degree. Nonetheless, infection is still largely fatal and the disease should not be taken lightly.
Morphology
- Large, enveloped, negative-sense RNA virus
- Bullet-shaped with short glycoprotein spikes
Types and Subtypes
Two Genera:
- Lyssaviruses: 7 genotypes
- Genotype 1 is classical rabies
- Genotypes 2-7 more limited in distribution
- Genotype 4 infects insectivorous bats
- Vesiculoviruses are all exotic to the UK:
- Vesicular Stomatitis Virus
- Ephemeral Fever
- Fish Rhabdoviruses, such as viral hemorrhagic syndrome and infectious haematopoetic necrosis virus
Virulence and Pathogenesis
- Rabies is moderately resistant: it can survive well in dark places at low temperatures for several days
- Infection occurs through a penetrating bite in which virus is transmitted via saliva
- Incubation period is variable but can be long (10 days to 12 months), and increases with distance of the bite to the CNS
- 80% show signs within 4 months
- Primary replication of the virus occurs in the muscle
- The virus gains access to nervous tissue and travels toward the brain, where it continues to replicate
- It then migrates down cranial nerves to infect salivary glands and the cornea
- Virus is shed in saliva and tears and can be shed BEFORE the onset of classical signs
- The onset of clinical signs in dogs and cats includes:
- Behavioral changes
- Pyrexia
- Salivation
- Dilation of pupils
- Two forms of the virus exist:
- Furious form:
- Common to cats and dogs
- Abnormal aggression, salivation, and attack without provocation
- Disordered wandering
- Incoordination, convulsions, coma and death within 3-10 days
- Dumb form
- May or may not follow Furious form
- Common to ruminants and horses
- Ruminal tympany, tenesmus, diarrhoea
- Paralysis of lower jaw, drooling saliva, tremors and progressive paralysis
- In dogs, a change in voice may be observed (bellowing)
- Furious form:
- Human infection is characterized by hydrophobia
Epidemiology
- Rabies is a NOTIFIABLE zoonosis
- Rabies is found worldwide, though currently considered exotic to the UK and Australia
Host Range:
- All mammals are susceptible
- Very susceptible: foxes, jackals, wolves
- Susceptible (10,000x virus necessary to infect): cats, rodents, bats, skunks, cattle, mongooses
- Moderately susceptible (100,000x virus necessary to infect): dogs, sheep, goats, horses, primates
- Isolates can show to some species specificity in their reservoir host
Reservoir species by region:
Region | Reservoir Species |
---|---|
Europe | Red fox |
Russia, Turkey, Middle East | Dog, Raccoon |
USA | Raccoon, Fox, Skunk |
Africa | Dog, Jackal, Mongoose |
Asia | Dog, Mongoose |
South America | Dog, Vampire bat |
Worldwide | Insectivorous Bats |
- The current position of DEFRA holds bat lyssaviruses to be present in the UK
- Human infection and death an occur after infection with bat rabies
- Nocturnal bat bites account for 50% of human cases in the USA
- Humans develop disease but excrete little virus
- Immune recovered animals are rare, but are not shown to be infections
Diagnosis
- Isolate and monitor for clinical signs
- In the field:
- Remove brain core sample via straw through occipital foramen in the direction of an eye
- Place contents in a 50% glyerol/PBS for FAT or virus isolation, or in 10% formaldehyde for histology
- Whole head can also be removed and sent to lab
- In the lab:
- Fluorescent Antibody Test (FAT) on smears or frozen sections of hippocampus or cerebellum should show presence of Negri bodies
- Being replaced by testing for monoclonal antibodies to nucleoprotein
- Histological detection of Negri bodies using Mann's or silver stains
- Intracerebral inoculation of mice followed by FAT testing of brain smears of affected mice
- RT-PCR on brain or saliva can be performed to determine genotype
- Fluorescent Antibody Test (FAT) on smears or frozen sections of hippocampus or cerebellum should show presence of Negri bodies
Rabies Control
For countries where rabies is considered exotic:
- 6 month quarantine of carnivores and ruminants (Norway, Sweden, Portugal, Australia, New Zealand)
- In the UK, this has been replaced by the Pet Travel Scheme (PETS)
For virus-endemic countries:
- Control in pets:
- Annual Vaccination:
- Antigenicity allows a single antigenic type to vaccinate
- Inactivated virus or canarypox recombinant viruses
- Control of stray population
- Muzzling in public
- Annual Vaccination:
- Control of wildlife reservoir hosts:
- Feeding vaccinated bait
- Secondary consequence of increasing reservoir host population (eg European foxes)
- Control in humans
- Prevention by vaccination with a single booster if bitten
- The current vaccine is grown in human diploid cells (HDCV) and is BPL-inactivated, and therefore costly
- Developing countries utilize older vaccines passaged from a 1939 case ("Flury" vaccines)
- If bitten and unvaccinated:
- Clean and disinfect wound
- Human anti-rabies immunoglobulin administered around bite
- Intramuscular vaccination program: 2 dose-1 dose-1 dose at 0, 7, and 14 days post-bite
- Prevention by vaccination with a single booster if bitten
For more on Rabies control in Europe, see here